TransMEM Gas Exchange -- Project 1, Aim 2

NCT01925729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Middle Ear Disease
Nasal Allergy

Interventions

BIOLOGICAL: ragweed
BIOLOGICAL: histamine
DRUG: pseudoephedrine
DRUG: Oxymetazoline

Sponsor

Cuneyt M. Alper

Collaborators

[object Object]